- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates ; volume:8 ; number:1 ; day:3 ; month:11 ; year:2023 ; pages:115-118 ; date:1.2024
PharmacoEconomics - open ; 8, Heft 1 (3.11.2023), 115-118, 1.2024
- Creator
-
Costin, Jeremy
Mouslim, Morgane C.
Socal, Mariana P.
Trujillo, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-023-00447-6
- URN
-
urn:nbn:de:101:1-2024032510225159046536
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Costin, Jeremy
- Mouslim, Morgane C.
- Socal, Mariana P.
- Trujillo, Antonio
- SpringerLink (Online service)
Other Objects (12)
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore
Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore
Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore